Following immune cells in people with Crohn's disease and ulcerative colitis over time
Follows adults with inflammatory bowel disease over time to study their immune cells.
Plain-language title generated from the registry record
Registry title: Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Key facts
- Where
- Bethesda, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT07619547, who can take part
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Trial code
- NCT07619547
- Record updated
- 10 November 2026
- Original description
Background:Read full original descriptionShow less
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in the digestive tract. Symptoms include stomach pain, diarrhea, and bleeding. Crohn's disease and ulcerative colitis are the 2 main types of IBD. Researchers want to conduct a natural history study to learn more about whether genetic factors can cause IBD; how immune cells contribute to IBD; and how diet, drugs, and disease affect those cells.
Objective:
To better understand IBD over time.
Eligibility:
Adults aged 18 to 85 years with Crohn's disease, ulcerative colitis, or another IBD. Their healthy relatives are also needed.
Design:
Affected participants will have clinic visits every 6 months for 3 years.
Once a year, they will have these procedures:
A physical exam with blood and stool samples.
Ultrasound of the abdomen. A wand will be rolled over the skin. It uses sound waves to capture images of the intestines.
Magnetic resonance imaging (MRI) scan. They will lie on a table that slides into a tube. Magnetic fields will capture images of the intestines.
Colonoscopy. A long, flexible tube with a video camera will be inserted into the rectum to view the entire colon. Up to 12 tissue samples may be taken.
Upper endoscopy, for those with Crohn's disease. A long, thin tube with a camera will be inserted through the mouth and into the first part of the small intestine. Up to 12 small tissue samples may be taken.
Questionnaires. Participants will answer questions about their disease and their diet.
Midyear visits will include a physical exam, blood and stool collection, ultrasound, and questionnaires
Healthy relatives will have 1 blood draw for genetic tests.
Exclusion: Evidence of significant medical illnesses that the investigators feel may interfere with study evaluations and procedures; An individual who meets any of the following criteria will be excluded from participation in this study:; Unable or unwilling to provide informed consent.
INCLUSION CRITERIA; In order to be eligible to participate in this study, an individual must meet all of the following criteria:; Affected Participant cohort:; Adults 18 - 85 years of age; History of:; a verifiable diagnosis of Crohn's disease, ulcerative colitis, or IBD known to be associated with a co-existing condition (such as CTLA4 deficiency or common variable immune deficiency) and which is supported by characteristic clinical features, radiographic or endoscopic findings, or consistent histopathologic mucosal changes related to chronic inflammation; and/or; a defined genetic syndrome/mutation linked to inflammatory bowel disease risk with or without symptoms or findings consistent with IBD; Presence of a referring community physician who would be able to manage care outside of NIH; Unaffected family member of participant: immediate relative to the enrolled participant (mother, father, sibling, or adult child) may be recruited and enrolled to improve interpretation of genetic results or expand the phenotype of the IBD; Adults 18 - 99 years of age; In good general health; No medical diagnosis of IBD.